Cutaneous Lupus

14 registered clinical trials studyying Cutaneous Lupus — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic NCT06599411	Assistance Publique - Hôpitaux de Paris	—
Recruiting	Determinants of Chronic Inflammatory Skin Disease Trajectories NCT05928169	University Hospital Schleswig-Holstein	—
Recruiting	Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus NCT06506214	University Hospital, Toulouse	—
Completed	Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus NCT05048238	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Terminated	Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus NCT03639857	David Weinstein	N/A
Recruiting	Maternal Autoimmune Disease Research Alliance (MADRA) Registry NCT03276923	Duke University	—
Completed	Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus NCT03288324	Children's Hospital Medical Center, Cincinnati	Phase 1 / Phase 2
Completed	Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases NCT03122431	University of Sao Paulo General Hospital	Phase 4
Completed	Cutaneous Lupus Medication Experience Study NCT02176148	Wake Forest University Health Sciences	—
Terminated	Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus NCT01389895	Amgen	Phase 1
Terminated	Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus NCT01164917	Amgen	Phase 1
Completed	Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus NCT01408199	Hospital Universitari Vall d'Hebron Research Institute	Phase 4
Completed	Duke Autoimmunity in Pregnancy Registry NCT00513591	Duke University	—
Recruiting	Duke Lupus Registry NCT00512694	Duke University	—